In vivo inhibition of antiphospholipid antibody‐induced pathogenicity utilizing the antigenic target peptide domain I of β2‐glycoprotein I: proof of concept von IOANNOU, Y., ROMAY‐PENABAD, Z., PERICLEOUS, C., GILES, I., PAPALARDO, E., VARGAS, G., SHILAGARD, T., LATCHMAN, D. S., ISENBERG, D. A., RAHMAN, A., PIERANGELI, S.

Volltext

Use of direct oral anticoagulants in antiphospholipid syndrome von Cohen, H., Efthymiou, M., Isenberg, D. A.

Volltext

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome von Arachchillage, D. R. J., Mackie, I. J., Efthymiou, M., Isenberg, D. A., Machin, S. J., Cohen, H.

Volltext

Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism von Arachchillage, D. R. J., Mackie, I. J., Efthymiou, M., Chitolie, A., Hunt, B. J., Isenberg, D. A., Khamashta, M., Machin, S. J., Cohen, H.

Volltext

AB0148 Differential Peripheral B-Cell Phenotype in Patients with Primary Sjögren's Syndrome (PSS) Compared To Secondary Sjögren's Syndrome Associated with Systemic Lupus Erythemato... von Thompson, N.L., Isenberg, D.A., Jury, E., Ciurtin, C.

Volltext

AB0534 Does the Presence of ANCA in Patients with Lupus Nephritis (LN) Help to Distinguish A Subset? von Neves, M., Irlapati, R.V.P., Isenberg, D.A.

Volltext

THU0509 Longer Duration of B Cell Depletion in Patients with Systemic Lupus Erythematosus is Associated with A Better Outcome von Rodríguez-García, V., Sapeta Dias, S., Nguyen, H., Pericleous, C., Isenberg, D.A.

Volltext

AB0558 What is the Prevalence of NON Criteria Antiphospholipid Antibodies in Patients with Antiphospholipid Syndrome? von Rodríguez-García, V., Ioannou, Y., Fernández-Nebro, A., Isenberg, D.A., Giles, I.

Volltext

AB0201 Investigation of BAFF/BLYS–binding receptors (BBR) on B cells from patients with systemic lupus erythematosus (SLE) von Martin-Garcia, G., Becerra, E., Leandro, M., Ortega, I.D.L.T., Isenberg, D.A., Cambridge, G.

Volltext

SAT0200 Effects of B cell depletion therapy on cutaneous lupus von Hofmann, S.C., Leandro, M.J., Morris, S., Isenberg, D.A.

Volltext

BILAG, SLEDAI, SIS, ECLAM, WAM, SLAM …. Thank you MAM von Isenberg, D.A.

Volltext

Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge von Ioannou, Y, Isenberg, D A

Volltext

Advances in IFN-alpha targeting-approaches for SLE treatment von Farinha, F., Isenberg, D.A.

Volltext

Serendipitous evidence of T lymphocyte activation in close female relatives of patients with systemic lupus erythematosus von Green, M.R.J, Kennell, A.S.M, Larche, M.J, Seifert, M.H, Isenberg, D.A, Salaman, M.R

Volltext

IgG Subclasses in Systemic Lupus Erythematosus and Other Autoimmune Rheumatic Diseases von Blanco, F., Kalsi, J., Ravirajan, C.T., Speight, P., Bradwell, A.R., Isenberg, D.A.

Volltext

Elevated Levels of the 90 kDa Heat Shock Protein (hsp90) in SLE Correlate with Levels of IL-6 and Autoantibodies to hsp90 von Ripley, B.J.M, Isenberg, D.A, Latchman, D.S

Volltext

Human monoclonal IgG anticardiolipin antibodies induce nitric oxide synthase expression von Alves, J. Delgado, Clapp, B.R., Stidwill, R., Chen, P.P., Hingorani, A.D., Singer, M., Isenberg, D.A.

Volltext

Antiphospholipid syndrome von Manson, J.J, Isenberg, D.A

Volltext

How does one assess and monitor patients with systemic lupus erythematosus in daily clinical practice? von Haq, Inam, Isenberg, D.A.

Volltext

Elevated Levels of the 90kDa Heat Shock Protein (hsp90) in SLE Correlate with Levels of IL-6 and Autoantibodies to hsp90 von Ripley, B.J.M, Isenberg, D.A, Latchman, D.S

Volltext